title: Defining the chemokine basis for leukocyte recruitment during viral encephalitis.
abstract: The encephalitic response to viral infection requires local chemokine production and the ensuing recruitment of immune and inflammatory leukocytes. Accordingly, chemokine receptors present themselves as plausible therapeutic targets for drugs aimed at limiting encephalitic responses. However, it remains unclear which chemokines are central to this process and whether leukocyte recruitment is important for limiting viral proliferation and survival in the brain or whether it is predominantly a driver of coincident inflammatory pathogenesis. Here we examine chemokine expression and leukocyte recruitment in the context of avirulent and virulent Semliki Forest virus (SFV) as well as West Nile virus infection and demonstrate rapid and robust expression of a variety of inflammatory CC and CXC chemokines in all models. On this basis, we define a chemokine axis involved in leukocyte recruitment to the encephalitic brain during SFV infection. CXCR3 is the most active; CCR2 is also active but less so, and CCR5 plays only a modest role in leukocyte recruitment. Importantly, inhibition of each of these receptors individually and the resulting suppression of leukocyte recruitment to the infected brain have no effect on viral titer or survival following infection with a virulent SFV strain. In contrast, simultaneous blockade of CXCR3 and CCR2 results in significantly reduced mortality in response to virulent SFV infection. In summary, therefore, our data provide an unprecedented level of insight into chemokine orchestration of leukocyte recruitment in viral encephalitis. Our data also highlight CXCR3 and CCR2 as possible therapeutic targets for limiting inflammatory damage in response to viral infection of the brain.
  
  
  OBJECTIVE
  Brain inflammation (encephalitis) in response to viral infection can lead to severe illness and even death. This therefore represents an important clinical problem and one that requires the development of new therapeutic approaches. Central to the pathogenesis of encephalitis is the recruitment of inflammatory leukocytes to the infected brain, a process driven by members of the chemokine family. Here we provide an in-depth analysis of the chemokines involved in leukocyte recruitment to the virally infected brain and demonstrate that simultaneous blockade of two of these receptors, namely, CXCR3 and CCR2, does not alter viral titers within the brain but markedly reduces inflammatory leukocyte recruitment and enhances survival in a murine model of lethal viral encephalitis. Our results therefore highlight chemokine receptors as plausible therapeutic targets in treating viral encephalitis.
authors.affiliation: Centre for Immunobiology, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
authors.forename: Daniela
authors.initials: D
authors.lastname: Michlmayr
authors.affiliation: Centre for Immunobiology, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom Clive.McKimmie@glasgow.ac.uk Gerard.Graham@glasgow.ac.uk.
authors.forename: Clive S
authors.initials: CS
authors.lastname: McKimmie
authors.affiliation: Centre for Immunobiology, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
authors.forename: Marieke
authors.initials: M
authors.lastname: Pingen
authors.affiliation: Animal Health and Veterinary Laboratories Agency, Addlestone, United Kingdom.
authors.forename: Ben
authors.initials: B
authors.lastname: Haxton
authors.affiliation: Animal Health and Veterinary Laboratories Agency, Addlestone, United Kingdom.
authors.forename: Karen
authors.initials: K
authors.lastname: Mansfield
authors.affiliation: Animal Health and Veterinary Laboratories Agency, Addlestone, United Kingdom.
authors.forename: Nicholas
authors.initials: N
authors.lastname: Johnson
authors.affiliation: Animal Health and Veterinary Laboratories Agency, Addlestone, United Kingdom.
authors.forename: Anthony R
authors.initials: AR
authors.lastname: Fooks
authors.affiliation: Centre for Immunobiology, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom Clive.McKimmie@glasgow.ac.uk Gerard.Graham@glasgow.ac.uk.
authors.forename: Gerard J
authors.initials: GJ
authors.lastname: Graham
mesh_terms: D018354:Alphavirus Infections / Q000276:immunology*; D000818:Animals; D001921:Brain / Q000473:pathology / Q000821:virology; D018925:Chemokines / Q000378:metabolism*; D004195:Disease Models, Animal; D018792:Encephalitis, Viral / Q000276:immunology*; D005260:Female; D007962:Leukocytes / Q000276:immunology*; D008810:Mice, Inbred C57BL; D019707:Receptors, Chemokine / Q000276:immunology; D012672:Semliki forest virus / Q000276:immunology; D016019:Survival Analysis; D019562:Viral Load; D014901:West Nile Fever / Q000276:immunology*; D014902:West Nile virus / Q000276:immunology
chemical_list: D018925:Chemokines; D019707:Receptors, Chemokine